论文部分内容阅读
目的:探讨血必净治疗窒息新生儿心肌损伤的临床疗效。方法:将62例窒息新生儿合并心肌损伤的患儿随机分为治疗组32例和对照组30例,对照组采用西医常规治疗,治疗组在对照组治疗的基础上加血必净治疗。结果:治疗组显效率为65.63%,对照组显效率为33.33%,两组比较,P<0.01。结论:血必净能明显改善窒息新生儿心肌损伤的临床症状,并能促进心肌细胞损伤的恢复。
Objective: To investigate the clinical efficacy of Xuebijing in the treatment of neonatal myocardial injury due to asphyxia. Methods: Sixty-two neonates with asphyxia and myocardial injury were randomly divided into treatment group (n = 32) and control group (n = 30). The control group was treated with western medicine. The treatment group was treated with Xuebijing in the control group. Results: The effective rate was 65.63% in the treatment group and 33.33% in the control group, P <0.01. Conclusion: Xuebijing can obviously improve the clinical symptoms of asphyxia neonatorum myocardial injury, and can promote the recovery of myocardial cell injury.